Episode 3: Young Adult AML: Understanding the Gaps & Closing Them
SpotifyDescription
AML is a complex and aggressive disease, but science is constantly evolving. This week we're talking about AML in young adults. Learn about the latest breakthroughs, unique challenges in treatment, and what’s next with Dr. Erin Feliciano, an AML AYA researcher.
Thank you for listening! Reach out to Mary at mary@healthtree.org if you are interested in joining our AYA Advisory Board or to share your thoughts on today's episode.
To keep learning about today's topic, check out this additional resource mentioned in today's episode!
If you want to talk to other listeners about this episode, join HealthTree Connect below and start the conversation!
Overview
This episode explores the unique challenges faced by adolescents and young adults (AYAs) with acute myeloid leukemia (AML), focusing on survival disparities, the impact of race, financial and logistical barriers to treatment, and the importance of patient stories. Dr. Erin Feliciano discusses her research on survival disparities among AYA AML patients, highlighting the need for more inclusive research and better access to clinical trials. The conversation emphasizes the importance of understanding the holistic experiences of patients and the need for systemic changes in healthcare to address these disparities.
Mary Arnett
Dr. Erin Feliciano
Transcript